共 171 条
[1]
Jordan MA(2004)Microtubules as a target for anticancer drugs Nat Rev Cancer 4 253-265
[2]
Wilson L(2009)Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance Mol Cancer Ther 8 2086-2095
[3]
Perez EA(2004)Paclitaxel for non-small cell lung cancer Expert Opin Pharmacother 5 1771-1780
[4]
Ramalingam S(2007)MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps Cancer Res 67 5865-5871
[5]
Belani CP(2003)Mechanisms of Taxol resistance related to microtubules Oncogene 22 7280-7295
[6]
Kasibhatla S(2010)Randomized phase II trial of all-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer J Clin Oncol 28 3463-3471
[7]
Baichwal V(2009)Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer J Clin Oncol 27 2516-2522
[8]
Cai SX(2007)HER2 and response to paclitaxel in node-positive breast cancer N Engl J Med 357 1496-1506
[9]
Roth B(2008)MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer Mol Cancer Ther 7 1150-1155
[10]
Skvortsova I(2005)Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer Ann Oncol 16 iv14-iv19